Same bet, opposite outcomes: Rede D’Or’s insurer-hospital machine compounds while Hapvida’s verticalization buckles under claims, losses and member cuts.
Same bet, opposite outcomes: Rede D’Or’s insurer-hospital machine compounds while Hapvida’s verticalization buckles under claims, losses and member cuts.
Brazil’s securities regulator has ordered a tender offer for Oncoclínicas shares, with analysts estimating the total outlay at R$ 12–14 billion — roughly double initial projections — as a parallel …
Brazilian startup PoliHealth is integrating genetic, laboratory, and lifestyle data into a single AI platform for clinicians, targeting R$8 million in revenue and 30,000 health professional users within three years.
You must be logged in to post a comment.